Author/Authors :
Rostamzadeh، Ayoob نويسنده Department of Anatomical Sciences, Kurdistan University of Medical Sciences, Sanandaj, Iran Rostamzadeh, Ayoob , AnjomShoa ، Maryam نويسنده Dept. of Anatomical Science, School of Dentistry, Isfahan (Khorasgan) Branch, Islamic Azad University, Isfahan, Iran. , , Kurd، Soleiman نويسنده Department of Biological Sciences and Biotechnology, School of Science, University of Kurdistan , , Chai، Jia-Ke نويسنده Department of Burn and Plastic Surgery, Burn and Plastic
Hospital of PLA General Hospital, Beijing, China , , Jahangiri، Faeze نويسنده Skin and Stem Cell Research Center, Tehran University of
Medical Sciences, Tehran, Iran , , Nilforoushzadeh، Mohammad Ali نويسنده , , Zare، Sona نويسنده Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran ,
Abstract :
Stem cell therapy, especially in the segment of mesenchymal stem cells (MSCs), is one of the most promising areas of regenerative medicine. According to research conducted by various researchers, Wharton’s Jelly mesenchymal stem cells (WJMSCs) have several advantages compared to others sources, in regenerative medicine: WJMSCs are more primary cells; WJMSCs can be easily isolated and without invasive procedures; WJMSCs have no ethical problems; WJMSCs are more cost effective than other sources of MSCs. Also, WJMSCs were demonstrated to express stem cell mesenchymal markers. Similar to bone marrow MSCs, WJMSCs express major histocompatibility complex (MHC) class I molecules. Although the aforementioned challenges must still be addressed, the potential of WJMSCs in skin regenerative clinical treatments is promising
